ASPR/BARDA is issuing this Request for Information (RFI) to assist in understanding the developmental landscape of next generation blood products that could be used to treat mechanical trauma and bleeding associated with acute radiation syndrome and potentially supplement the blood supply in the wake of a mass casualty event such as a nuclear or radiological scenario.
BARDA intends to use responses to this RFI for planning potential future acquisitions.
BARDA seeks pertinent marketplace data to strengthen BARDA’s understanding of the current and future marketplace as well as enhance its ability to obtain quality services and products economically, and to efficiently and lawfully establish potential vendor source files and listings.
BARDA will not award any potential contracts under this notice. This is strictly for market research.
Use this link for more more information and for the response submission form: https://beta.sam.gov/opp/18ed7d8dfea94439bb5661005ed48ed1/view?keywords=BARDA_Next_Generation_Blood_Products_RFI%20&sort=-relevance&index=&is_active=true&page=1
1000 Westgate Drive